Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?

Literature DB >> 16200578

Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?

Luke Dawson¹, Andrew Tobin, Peter Smith, Tom Gordon.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2005 PMID： 16200578 DOI： 10.1002/art.21347

Source DB: PubMed Journal: Arthritis Rheum ISSN： 0004-3591

Keyword Cloud
Cited

× No keyword cloud information.

27 in total

1. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.

Authors: Cuong Q Nguyen; Hyuna Kim; Janet G Cornelius; Ammon B Peck
Journal: J Immunol Date: 2007-08-15 Impact factor: 5.422

Review 2. A conspicuous role for B cells In Sjögren's syndrome.

Authors: Pierre Youinou; Valérie Devauchelle; Pascal Hutin; Rozenn Le Berre; Alain Saraux; Jacques-Olivier Pers
Journal: Clin Rev Allergy Immunol Date: 2007-06 Impact factor: 8.667

Review 3. Pathogenesis of Sjögren's syndrome.

Authors: Nikolay P Nikolov; Gabor G Illei
Journal: Curr Opin Rheumatol Date: 2009-09 Impact factor: 5.006

4. M3 muscarinic acetylcholine receptor-reactive Th17 cells in primary Sjögren's syndrome.

Authors: Saori Abe; Hiroto Tsuboi; Hanae Kudo; Hiromitsu Asashima; Yuko Ono; Fumika Honda; Hiroyuki Takahashi; Mizuki Yagishita; Shinya Hagiwara; Yuya Kondo; Isao Matsumoto; Takayuki Sumida
Journal: JCI Insight Date: 2020-08-06

5. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.

Authors: B T Kurien; A Dsouza; A Igoe; Y J Lee; J S Maier-Moore; T Gordon; M Jackson; R H Scofield
Journal: Clin Exp Immunol Date: 2013-07 Impact factor: 4.330

Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?

1. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.

Review 2. A conspicuous role for B cells In Sjögren's syndrome.

Review 3. Pathogenesis of Sjögren's syndrome.

4. M3 muscarinic acetylcholine receptor-reactive Th17 cells in primary Sjögren's syndrome.

5. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.

Review 6. The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.

Review 7. The clinical approach to autonomic failure in neurological disorders.

Review 8. Sjögren's syndrome--study of autoantigens and autoantibodies.

9. Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis.

10. Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndrome.